Genetic Signatures IPO closes oversubscribed
Press Release
Read MoreGenetic Signatures achieves first sales of EasyScreen™ Respiratory Virus Detection Kit
Press Release
Read MoreGenetic Signatures IPO now open to 20 March. Supplementary Prospectus now available. The Minimum Subscription under the Offer is fully underwritten by the Lead Manager, Lodge Corporate Pty Ltd.
Genetic Signatures has issued a Supplementary Prospectus to extend the closing date of its IPO to 5.00pm (AEDT) on 20 March 2015. This Supplementary Prospectus supplements, and must be read together with, the Prospectus dated 7 November 2014 (“Prospectus”) relating to an offer of Shares by the Company. The prospectus and supplementary prospectus may be…
Read MoreGenetic Signatures Prepares for IPO: Prospectus now available
Exciting Australian Biotech offers Institutional & Retail Shareholders Access to Global $5.3B Molecular Diagnostics Market Sydney, Australia – 18 November 2014: Genetic Signatures Ltd has launched its prospectus offering institutional and retail investors the opportunity to invest in the exciting growing global molecular diagnostics market prior to the Company’s listing on the Australian Stock Exchange on…
Read MoreGenetic Signatures expands its Board of Directors with the appointment of Pat Noland
Sydney, Australia 30th October 2014 Genetic Signatures Ltd today announced the appointment of Pat Noland to its Board of Directors in the capacity of non-executive director. Mr. Noland currently serves as Chief Executive Officer of StrataDx, a leading provider of high-quality pathology services in the dermatology, urology, podiatry, oral pathology, gastroenterology, and gynecology segments. Mr.…
Read MoreGenetic Signatures EasyScreen™ Enteric Bacteria Detection Kit receives the CE-IVD Mark
Genetic Signatures has increased its suite of CE- marked IVD products with the registration of the EasyScreen™ Enteric Bacteria Detection Kit. The EasyScreen™ Enteric Bacteria Detection Kit is a real-time PCR kit for the detection of i) Salmonella spp., (ii) Campylobacter spp., (iii) Shigella spp., (iv) Yersinia enterocolitica, (v) toxigenic C. difficile and (vi) Listeria…
Read MoreGenetic Signatures welcomes Mike Aicher as Executive Director – U.S. Operations
Genetic Signatures has recently appointed Mike Aicher to the company’s Board of Directors as Executive Director – U.S. Operations. Mr. Aicher was CEO of National Genetics Institute (NGI), a company he co-founded in 1991, that later became a wholly owned subsidiary of Laboratory Corporation of America (LabCorp). More recently, Mr. Aicher led LabCorp’s Western Division…
Read MoreGenetic Signatures receives TGA registration for first IVDs in Australia
We are pleased to announce that we have been granted TGA approval for our first IVDs in Australia. The following products are now listed on the Australian Register of Therapeutic Goods (ARTG). [table id=23 /] The next products that will be registered are SP003 EasyScreen™ Sample Processing Kit (Mag Beads) and EV001 (& HT) EasyScreen™ Enteric Viral Detection Kit.
Read MoreRecent publications highlight the clinical performance of Genetic Signatures EasyScreen™ Enteric Pathogen Detection Assays
Two recent publications highlight the clinical performance of Genetic Signatures EasyScreen™ Enteric Pathogen Detection Assays. The most recent publication by Stark et al. evaluates the clinical performance of the EasyScreen™ Enteric Protozoan Detection Kit. Stark D, Roberts T, Marriott D, Harkness J. Evaluation of the EasyScreen™ Enteric Parasite Detection Kit for the detection of Blastocystis spp., Cryptosporidium spp., Dientamoeba fragilis, Entamoeba complex, and Giardia intestinalis from clinical stool samples. Diagnostic Microbiology…
Read MoreGenetic Signatures will present on its in development MRSA assay at The Australian Society for Microbiology Annual Meeting 2014
Genetic Signatures will be presenting and exhibiting at The Australian Society for Microbiology, Annual Scientific Meeting, from 6 – 9 July 2014 in Melbourne, Australia. The Australian Society for Microbiology Annual Scientific Meeting is the largest microbiology conference held in Australia and attracts approximately 600 microbiologists, allied professionals, researchers and academics from across the country…
Read More